Second-trimester dimeric inhibin-A in Down's syndrome screening

Prenatal Diagnosis

Volumn 16, Issue 12, 1996, Pages 1101-1110

  Spencer, K ^a   Wallace, E M ^b   Ritoe, S ^b  

^a OLDCHURCH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Dimeric inhibin A; Down's syndrome screening; Second trimester serum screening

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; INHIBIN;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL BLOOD; MATHEMATICAL MODEL; PRIORITY JOURNAL; SCREENING; SECOND TRIMESTER PREGNANCY; SERODIAGNOSIS;

ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HUMANS; INHIBINS; MACROMOLECULAR SUBSTANCES; MATERNAL AGE; MODELS, STATISTICAL; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS;

EID: 0030444220     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0223(199612)16:12<1101::AID-PD5>3.0.CO;2-7     Document Type: Article

References (40)

1. Aitken, D.A., McKinnon, D., Crossley, J.A., Graham, G.W., Berry, F., Spencer, K., Macri, J.N., Connor, J.M. (1994). Changes in the maternal serum concentrations of PAPP-A and SP-1 in Down's syndrome pregnancies between the first and second trimester, J. Med. Genet., 32, 170.
2. Aitken, D.A., Wallace, E.M., Crossley, J.A., Swanston, I.A., van Pareren, Y., van Maarle, M., Gnome, N.P., Macri, J.N., Connor, J.M. (1996). Dimeric inhibin-A as a marker for Down's syndrome and trisomy 18 in early pregnancy, N. Engl. J. Med., 334, 1321-1326.
3. Canick, J.A., Lambert-Messerlian, G.M., Palomaki, G.E., Schnever, A.L., Tumber, M.B., Knight, G.J., Haddow, J.E. (1994). Maternal serum dimeric inhibin is elevated in Down syndrome pregnancy, Am. J. Hum. Genet., 55, A9.
4. Cuckle, H.S., Wald, N.J., Thompson, S.G. (1987). Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein levels, Br. J. Obstet. Gynaecol., 94, 387-402.
5. Cuckle, H.S., Holding, S., Jones, R. (1994). Maternal serum inhibin levels in second trimester Down's syndrome pregnancies, Prenat. Diagn., 14, 387-390.
6. Cuckle, H.S., Holding, S., Jones, R., Wallace, E.M., Groome, N.P. (1995). Maternal serum dimeric inhibin-A in second trimester Down's syndrome pregnancies, Prenat. Diagn., 15, 385-386.
7. Groome, N.P., O'Brien, M. (1993). Two-site immunoassays for inhibin and its subunits. Further applications of the synthetic peptide approach, J. Immunol. Methods, 165, 167-176.
8. Groome, N.P., Illingworth, P.J., O'Brien, M., Cooke, I., Ganesan, T.S., Baird, D.T., McNeilly, A.S. (1994). Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay, Clin. Endocrinol., 40, 717-723.
9. Healy, D.L., Polson, D., Yohkachiya, T., De Krester, D. (1990). Inhibin and related peptides in pregnancy, Bailliere's Clin. Endocrinol. Metab., 4, 233-247.
10. Illingworth, P.J., Groome, N.P., Duncan, W.C., Grant, V.E., Tovanabutra, S., Baird, D.T., McNeilly, A.S. (1996). Measurement of circulating inhibin forms during the establishment of pregnancy, J. Clin. Endocrinol. Metabol., 81, 1471-1475.
11. Macri, J.N., Kasturi, R.V., Krantz, D.A., Cook, E.J., Moore, N.D., Young, J.A., Romero, K., Larsen, J.W. (1990). Maternal serum Down syndrome screening: free beta protein is a more effective marker than human chorionic gonadotropin, Am. J. Obstet. Gynecol., 163, 1248-1253.
12. Macri, J.N., Spencer, K., Anderson, R., Cooke, E.J. (1993). Free beta chorionic gonadotropin: a cross reactive study of two immunometric assays used in prenatal maternal serum screening for Down syndrome, Ann. Clin. Biochem., 30, 94-98.
13. Massague, J. (1990). The transforming growth factor beta family, Annu. Rev. Cell Biol., 6, 597-641.
14. Office of Population Censuses and Surveys (1991-1994). Birth Statistics, Series FM1, Nos 18-21, London: HMSO.
15. Petraglia, F., Sawchenko, P., Lim, A.T.W., Rivier, J., Vale, W. (1987). Localization, secretion and action of inhibin in human placenta, Science, 237, 187-189.
16. Reynolds, T.M., Penney, M.D. (1990). The mathematical basis of multivariate risk screening with special reference to screening for Down's syndrome associated pregnancy, Ann. Clin. Biochem., 27, 452-458.
17. Robertson, D.M., Sullivan, J., Cahir, N. (1995). Inhibin forms in human plasma, J. Endocrinol., 144, 261-269.
18. Royston, P., Thompson, S.G. (1992). Model based screening by risk with application to Down's syndrome, Stats. Med., 11, 257-258.
19. Schneyer, A.L., Mason, A.J., Barton, L.E., Ziegner, J.R., Crowley, W.F. (1990). Immunoreactive inhibin α-subunit in human serum: implications for radioimmunoassay, J. Clin. Endocrinol. Metab., 70, 1208-1212.
20. Seth, J., Sturgeon, C.M., Ellis, A.R. (1995). UKNEQAS for Peptide Hormones and Related Substances: Annual Review 1994, Edinburgh: UKNEQAS.
21. Spencer, K. (1991a). Evaluation of an assay of the free beta subunit of choriogonadotropin and its potential value in screening for Down's syndrome, Clin. Chem., 37, 809-814.
22. Spencer, K. (1991b). Analytical error in the calculation of risk in Down's syndrome screening, Proc. ACB Nat. Meeting, 107.
23. Spencer, K. (1993). Screening for Down's syndrome. The role of intact hCG and free subunit measurement, Scand. J. Clin. Lab. Invest., 53 (Suppl. 216), 79-96.
24. Spencer, K. (1994a). The measurement of hCG subunits in screening for Down's syndrome. In: Grudzinskas, J.G., Chard, T., Chapman, M., Cuckle, H. (Eds). Screening for Down's Syndrome, Cambridge: Cambridge University Press, pp. 85-100.
25. Spencer, K. (1994b). Despistage de la trisomie 21 a l'aide de la beta hCG libre: notre experience sur trois ans, Med. Foetale Echographie Gynecol., 20, 67-69.
26. Spencer, K. (1994c). Is the measurement of unconjugated oestriol of value in screening for Down's Syndrome? In: Grudzinskas, J.G., Chard, T., Chapman, M., Cuckle, H. (Eds). Screening for Down's Syndrome, Cambridge: Cambridge University Press, pp. 141-161.
27. Spencer, K., Carpenter, P. (1985). Screening for Down's syndrome using serum alpha-fetoprotein: a retrospective study indicating caution, Br. Med. J., 290, 1940-1943.
28. Spencer, K., Macri, J.N. (1994). The use of free beta hCG in antenatal screening for Down's syndrome, Br. J. Obstet. Gynaecol., 101, 175-176.
29. Spencer, K., Coombes, E.J., Mallard, A.S., Milford Ward, A. (1992). Free beta human choriogonadotropin in Down's syndrome screening: a multicentre study of its role compared with other biochemical markers, Ann. Clin. Biochem., 29, 506-518.
30. Spencer, K., Aitken, D.A., Muller, F. (1993a). Biochemical markers of trisomy 21 in amniotic fluid, Clin. Chem., 39, 1169.
31. Spencer, K., Woods, P.J., Anthony, F.W. (1993b). Elevated levels of maternal serum inhibin immunoreactivity in second trimester pregnancies affected by Down's syndrome, Ann. Clin. Biochem., 30, 219-220.
32. Spencer, K., Macri, J.N., Anderson, R.W., Aitken, D.A., Berry, E., Crossley, J.A., Woods, P.J., Coombes, E.J., Stroud, M., Worthington, D.J., Doran, J., Barbour, H., Wilmot, R. (1993c). Dual analyte immunoassay in neural tube defect and Down's syndrome screening: results of a multicentre clinical trial, Ann. Clin. Biochem., 30, 394-401.
33. Van Lith, J.M.M., Pratt, J.J., Beekhuis, J.R., Mantingh, A. (1992). Second trimester maternal serum immunoreactive inhibin as a marker for fetal Down's syndrome, Prenat. Diagn., 12, 801-806.
34. Van Lith, J.M.M., Mantingh, A., Pratt, J.J. (1994). First trimester maternal serum immunoreactive inhibin in chromosomally normal and abnormal pregnancies, Obstet. Gynecol., 83, 661-664.
35. Wald, N.J., Cuckle, H.S., Densem, J.W., Kennard, A., Smith, D. (1992). Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight, Br. J. Obstet. Gynaecol., 99, 144-149.
36. Wald, N.J., Densem, J.W., George, L., Muttukrishna, S., Knight, P.G. (1996). Prenatal screening for Down's syndrome using inhibin-A as a serum marker, Prenat. Diagn., 16, 143-153.
37. Wallace, E.M., Harkness, L.M., Burns, S., Liston, W.A. (1994). Evaluation of maternal serum immunoreactive inhibin as a first trimester marker of Down's syndrome. Clin. Endocrinol., 41, 483-486.
38. Wallace, E.M., Grant, V.E., Swanston, I.A., Groome, N.P. (1995). Evaluation of maternal serum dimeric inhibin-A as a first trimester marker of Down's syndrome, Prenat. Diagn., 15, 359-362.
39. Wallace, E.M., Swanston, I.A., McNeilly, A.S., Ashby, J.P., Blundell, G., Calder, A.A., Groome, N.P. (1996). Second trimester screening for Down's syndrome using maternal serum dimeric inhibin-A, Clin. Endocrinol., 44, 17-21.
40. Ying, S.-Y. (1988). Inhibins, activins and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone, Endocrine Rev., 9, 267-293.